论文部分内容阅读
目的:观察百乐眠治疗功能性消化不良的临床疗效。方法:选取本院2015年1月~2016年2月收治的功能性消化不良患者共120例,随机分为A、B、C三组,每组40例。A组使用泮托拉唑+莫沙必利治疗,B组在A组基础上加用氟哌噻吨美利曲辛,C组在A组基础上加用百乐眠,疗程2周。结果:B组有效率92.8%、C组有效率90.2%,均显著高于A组的68.3%,A、B组与C组之间差异有统计学意义(P<0.05),B、C组之间无明显差异(P>0.05)。结论:百乐眠可有效改善功能性消化不良患者临床症状,且安全、有效,值得推广。
Objective: To observe the clinical efficacy of Bailemian in treating functional dyspepsia. Methods: A total of 120 patients with functional dyspepsia admitted from January 2015 to February 2016 in our hospital were randomly divided into three groups (A, B and C), 40 in each. Group A was treated with pantoprazole + mosapride, group B was given flupentixol and melitracen on the basis of group A, and group C was given Baile Mian sleep on the basis of group A for two weeks. Results: The effective rate was 92.8% in group B and 90.2% in group C, which was significantly higher than that in group A (68.3%). There was a significant difference between group A and group B (P <0.05) No significant difference between (P> 0.05). Conclusion: Bailemian can effectively improve the functional symptoms of patients with dyspepsia, and safe, effective and worth promoting.